The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

2.50
Hdl Handle:
http://hdl.handle.net/10029/5604
Title:
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
Authors:
Melker, Hester E de; Berbers, Guy A M; Hahné, Susan J M; Rümke, Hans; Hof, Susan van den; Wit, G Ardine de; Boot, Hein J
Abstract:
We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands. Data on seroprevalence of varicella zoster virus in the general population (1995-1996), consultations of general practitioners for varicella (2000-2002) and herpes zoster (1998-2001) and hospital admissions due to varicella (1994-2001) and herpes zoster (1994-2001) in The Netherlands were analysed. The seropositivity increased sharply with age from 18.4% for both 0- and 1-year-olds, to 48.9%, 59.0%, 75.7% and 93.0% for 2-, 3-, 4- and 5-year-olds, respectively, and varied between 97.5% and 100% for older age groups. The average annual incidence of GP-consultations amounted to 253.5 and 325.0 per 100,000 for varicella and herpes zoster, respectively. The incidence of hospital admission due to varicella and herpes zoster was 1.3 (2.3 including side diagnosis) and 2.7 (5.8) per 100,000, respectively. Whilst for varicella, the incidence of GP-consultations and hospital admissions were highest in childhood, for herpes zoster, these were highest in elderly. Insight into epidemiology of varicella zoster is needed for the assessment of the desirability of introduction of routine varicella zoster vaccination.
Citation:
Vaccine 2006, 24(18):3946-52
Issue Date:
1-May-2006
URI:
http://hdl.handle.net/10029/5604
DOI:
10.1016/j.vaccine.2006.02.017
PubMed ID:
16564115
Type:
Article
Language:
en
ISSN:
0264-410X
Appears in Collections:
Vaccines and Vaccination

Full metadata record

DC FieldValue Language
dc.contributor.authorMelker, Hester E de-
dc.contributor.authorBerbers, Guy A M-
dc.contributor.authorHahné, Susan J M-
dc.contributor.authorRümke, Hans-
dc.contributor.authorHof, Susan van den-
dc.contributor.authorWit, G Ardine de-
dc.contributor.authorBoot, Hein J-
dc.date.accessioned2006-10-26T10:58:53Z-
dc.date.available2006-10-26T10:58:53Z-
dc.date.issued2006-05-01-
dc.identifier.citationVaccine 2006, 24(18):3946-52en
dc.identifier.issn0264-410X-
dc.identifier.pmid16564115-
dc.identifier.doi10.1016/j.vaccine.2006.02.017-
dc.identifier.urihttp://hdl.handle.net/10029/5604-
dc.description.abstractWe studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands. Data on seroprevalence of varicella zoster virus in the general population (1995-1996), consultations of general practitioners for varicella (2000-2002) and herpes zoster (1998-2001) and hospital admissions due to varicella (1994-2001) and herpes zoster (1994-2001) in The Netherlands were analysed. The seropositivity increased sharply with age from 18.4% for both 0- and 1-year-olds, to 48.9%, 59.0%, 75.7% and 93.0% for 2-, 3-, 4- and 5-year-olds, respectively, and varied between 97.5% and 100% for older age groups. The average annual incidence of GP-consultations amounted to 253.5 and 325.0 per 100,000 for varicella and herpes zoster, respectively. The incidence of hospital admission due to varicella and herpes zoster was 1.3 (2.3 including side diagnosis) and 2.7 (5.8) per 100,000, respectively. Whilst for varicella, the incidence of GP-consultations and hospital admissions were highest in childhood, for herpes zoster, these were highest in elderly. Insight into epidemiology of varicella zoster is needed for the assessment of the desirability of introduction of routine varicella zoster vaccination.en
dc.format.extent137529 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoenen
dc.titleThe epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.en
dc.typeArticleen
dc.format.digYES-

Related articles on PubMed

All Items in WARP are protected by copyright, with all rights reserved, unless otherwise indicated.